During the past decade, Hopital Claude Huriez;Gastro Enterologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Claude Huriez;Gastro Enterologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Rennes University Hospital" with 2 trials sponsored, "Takeda" with 1 trials sponsored and "Tigenix S.A.U." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Claude Huriez;Gastro Enterologie" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Claude Huriez;Gastro Enterologie" are "Crohn's Disease" (2 trials), "Hepatitis C" (2 trials), "Hepatitis C, Chronic" (2 trials), "Carcinoma, Hepatocellular" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Hopital Claude Huriez;Gastro Enterologie" in a lesser frequency.

Most popular intervention types in "Hopital Claude Huriez;Gastro Enterologie" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ribavirin" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Cx601" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Claude Huriez;Gastro Enterologie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Claude Huriez;Gastro Enterologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital Claude Huriez;Gastro Enterologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Claude Huriez;Gastro Enterologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".